113 related articles for article (PubMed ID: 18638490)
1. Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
Abe F; Ueyama J; Kimata A; Kato M; Hayashi T; Nadai M; Saito H; Takeyama N; Noguchi H; Hasegawa T
Life Sci; 2008 Aug; 83(7-8):229-35. PubMed ID: 18638490
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats.
Noda T; Abe F; Ueyama J; Kato M; Katoh M; Nadai M; Saito H; Hasegawa T
J Infect Chemother; 2011 Apr; 17(2):207-13. PubMed ID: 20835743
[TBL] [Abstract][Full Text] [Related]
3. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
[TBL] [Abstract][Full Text] [Related]
4. Role of plasma proteins in pharmacokinetics of micafungin, an antifungal antibiotic, in analbuminemic rats.
Abe F; Ueyama J; Kawasumi N; Nadai M; Hayashi T; Kato M; Ohnishi M; Saito H; Takeyama N; Hasegawa T
Antimicrob Agents Chemother; 2008 Sep; 52(9):3454-6. PubMed ID: 18591270
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport.
Yamaguchi S; Zhao YL; Nadai M; Yoshizumi H; Cen X; Torita S; Takagi K; Takagi K; Hasegawa T
Antimicrob Agents Chemother; 2006 Jan; 50(1):80-7. PubMed ID: 16377671
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.
Sugie M; Asakura E; Zhao YL; Torita S; Nadai M; Baba K; Kitaichi K; Takagi K; Takagi K; Hasegawa T
Antimicrob Agents Chemother; 2004 Mar; 48(3):809-14. PubMed ID: 14982769
[TBL] [Abstract][Full Text] [Related]
7. In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.
Yanni SB; Augustijns PF; Benjamin DK; Brouwer KL; Thakker DR; Annaert PP
Drug Metab Dispos; 2010 Oct; 38(10):1848-56. PubMed ID: 20606004
[TBL] [Abstract][Full Text] [Related]
8. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
[TBL] [Abstract][Full Text] [Related]
9. Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.
Kato Y; Takahara S; Kato S; Kubo Y; Sai Y; Tamai I; Yabuuchi H; Tsuji A
Drug Metab Dispos; 2008 Jun; 36(6):1088-96. PubMed ID: 18339814
[TBL] [Abstract][Full Text] [Related]
10. Involvement of sulfate conjugation and multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of garenoxacin in rats.
Hayashi T; Abe F; Kato M; Saito H; Ueyama J; Kondo Y; Imai K; Katoh M; Nadai M; Hasegawa T
J Infect Chemother; 2011 Feb; 17(1):24-9. PubMed ID: 20676911
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats.
Mano Y; Usui T; Kamimura H
Eur J Drug Metab Pharmacokinet; 2006; 31(2):117-21. PubMed ID: 16898080
[TBL] [Abstract][Full Text] [Related]
12. Quantitative time-lapse imaging-based analysis of drug-drug interaction mediated by hepatobiliary transporter, multidrug resistance-associated protein 2, in sandwich-cultured rat hepatocytes.
Nakanishi T; Shibue Y; Fukuyama Y; Yoshida K; Fukuda H; Shirasaka Y; Tamai I
Drug Metab Dispos; 2011 Jun; 39(6):984-91. PubMed ID: 21415249
[TBL] [Abstract][Full Text] [Related]
13. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
Johnson DR; Habeebu SS; Klaassen CD
Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
[TBL] [Abstract][Full Text] [Related]
14. Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats.
Hotta K; Ueyama J; Tatsumi Y; Tsukiyama I; Sugiura Y; Saito H; Matsuura K; Hasegawa T
Anticancer Res; 2015 Sep; 35(9):4681-9. PubMed ID: 26254357
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Hirouchi M; Suzuki H; Sugiyama Y
Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
[TBL] [Abstract][Full Text] [Related]
16. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
[TBL] [Abstract][Full Text] [Related]
17. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
[TBL] [Abstract][Full Text] [Related]
18. Role of rat multidrug resistance protein 2 in plasma and biliary disposition of dibromosulfophthalein after microsomal enzyme induction.
Johnson DR; Klaassen CD
Toxicol Appl Pharmacol; 2002 Apr; 180(1):56-63. PubMed ID: 11922777
[TBL] [Abstract][Full Text] [Related]
19. Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.
Yue W; Lee JK; Abe K; Sugiyama Y; Brouwer KL
Drug Metab Dispos; 2011 Mar; 39(3):441-7. PubMed ID: 21106720
[TBL] [Abstract][Full Text] [Related]
20. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
